Acasti Pharma Inc EV/EBIT
Quel est le EV/EBIT de Acasti Pharma Inc?
Le EV/EBIT de Acasti Pharma Inc est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Acasti Pharma Inc
Que fait Acasti Pharma Inc?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Entreprises avec ev/ebit similaire à Acasti Pharma Inc
- Halo Collective a EV/EBIT de N/A
- Nkarta a EV/EBIT de N/A
- Manugraph India a EV/EBIT de N/A
- Guild Esports Plc a EV/EBIT de N/A
- Clarity Gold a EV/EBIT de N/A
- Radha Madhav a EV/EBIT de N/A
- Acasti Pharma Inc a EV/EBIT de N/A
- Akers Biosciences Inc a EV/EBIT de N/A
- Agios Pharmaceuticals Inc a EV/EBIT de N/A
- Generation Bio Co a EV/EBIT de N/A
- Purple Biotech a EV/EBIT de N/A
- Panbela Therapeutics a EV/EBIT de N/A
- Continental Materials a EV/EBIT de N/A